The largest database of trusted experimental protocols

7 protocols using streptomycin p4333

1

Monocyte-Derived Dendritic Cell Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mature dendritic cells were differentiated from blood monocytes as previously described (Bruger et al, 2020 (link)). Briefly, monocytes (isolated from mononuclear cells of non-cancerous patients as described above) were resuspended in RPMI-1640 complemented with 10% FCS (Sigma-Aldrich), 200 nM L-alanyl-L-glutamine dipeptide (35050-038, GlutaMAX; Gibco), 100 U/ml penicillin + 100 μg/ml streptomycin (P4333; Sigma-Aldrich), 100 ng/ml of clinical grade GM-CSF (NDC0024-5843-05, Leukine [Sargramostim]; Sanofi-Aventis), and 30 ng/ml (5 × 105 U/ml) IL-4 (in-house) (DC medium). Monocytes were seeded in a 12-well tissue culture plate at 106 cells/well, and incubated for 5 d at 37°C and 5% CO2. Dendritic cells were matured at Day 5 with 50 μg/ml Poly-IC (P1530; Sigma-Aldrich) and 10 ng/ml TNF-α (300-01A; PeproTech) in DC medium for another 2 d at 37°C and 5% CO2. Cells were harvested at Day 7 and checked by flow cytometry to confirm their phenotype (CD3, CD19, CD14, CD11c+, CD1a+, CD83+) (see antibodies for flow cytometry). Mature DC were frozen at −80°C in 50% RPMI-1640, 40% FCS, and 10% DMSO for later use.
+ Open protocol
+ Expand
2

Characterizing Human Schlemm's Canal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
This study examined 3 primary SC cell “lines” from non-glaucomatous human donors, aged 34 (SC58), 44 (SC67) and 68 (SC65) years. SC cells were isolated using the cannulation technique of Stamer et al. (Stamer et al., 1998 (link)) and characterized based on expression of VE-cadherin and fibulin-2 (Perkumas and Stamer, 2012 (link)). SC cells between passage 3 and 5 were used for all experiments. Although primary cell lines are typically referred to as cell “strains”, we refer to these as cell “lines” to avoid confusion with the mechanical “strain” applied to the cells.
Cells were cultured in low glucose DMEM containing 25 mM HEPES buffer (Gibco 12320, Life Technologies Co, USA), 10% fetal bovine serum (Hyclone SH30070.03, Thermo Scientific, USA), 100 U/mL penicillin and 100 μg/mL streptomycin (P4333, Sigma Aldrich, UK). SC cells were cultured in 5% CO2 in a humid incubator at 37°C, and passaged prior to confluence using trypsin-EDTA (T4049 Sigma-Aldrich, UK).
+ Open protocol
+ Expand
3

Metabolic Activation of Bone Marrow Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow cells were isolated from femurs of 3–6 months old male TG2 null mice and their wild type counterparts. Bone marrow macrophages (BMDMs) were differentiated in DMEM supplemented with 10% FBS (12106C), 2 mM L-glutamine (G7513), 1 mM Na-pyruvate (S8636), 50 μM 2-mercaptoethanol (M3148) and 100 U/ml penicillin/100 μg/ml streptomycin (P4333) all from Sigma-Aldrich and 10% L929 fibroblast conditioned media for 7 days. For metabolic activation, differentiated macrophages were treated with a combination of 30 mM D-glucose (G8270), 10 nM insulin (12643) and 0.4 mM sodium-palmitate (P9767) all from Sigma-Aldrich for 24 h (16). Sodium palmitate was prepared by diluting a 200 mM stock solution in 70% ethanol into 10% fatty acid-free, low-endotoxin BSA (Sigma Aldrich, A8806 adjusted to pH 7.4) to obtain a 5 mM palmitate-BSA stock solution that was filtered using a 0.22-μm low-protein binding filter (Millipore). BSA/ethanol was used in control treatments during the protocol. In some experiments during the 24 h metabolic activation BMDMs were treated with PP2 (Sigma Aldrich, 529573), a reversible ATP-competitive inhibitor of the Src family of protein tyrosine kinases, in 2 µM final concentration or 0.5 mg/ml RGD peptide (Cayman Chemical, 529573).
+ Open protocol
+ Expand
4

In Vitro T Cell Polarization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified naïve CD4+ T cells were cultured in 24-well (4 x 105 cells per well), 48-well (2 x 105 cells per well) or 96-well (1 x 105 cells per well) plates coated with 5 μg/mL anti-CD3ϵ antibody (145-2C11; Biolegend) in IMDM medium (12440-061; Invitrogen) containing 1 μg/mL anti-CD28 antibody (37.51; Biolegend), 10% FBS, 1x streptomycin-penicillin (containing 100 U/mL penicillin and 100 μg/mL streptomycin, P4333; Sigma), and 55 μM β-mercaptoethanol (20985-023; Invitrogen, Waltham, MA, USA). In addition, the following cytokines and antibodies were added in each polarizing condition: 20 ng/mL IL-2 (570402; Biolegend), 1 μg/mL anti-IFN-γ (XMG1.2; Biolegend), and 1 μg/mL anti-IL-4 (11B11; Biolegend) for Th0; 20 ng/mL IL-2, 20 ng/mL IL-12 (577002; Biolegend), and 1 μg/mL anti-IL-4 for Th1; 20 ng/mL IL-2, 100 ng/mL IL-4 (574306; Biolegend), and 1 μg/mL anti-IFN-γ for Th2; 20 ng/mL IL-6 (575706; Biolegend), and 3 ng/mL TGF-β1 (100-21C; PeproTech, Cranbury, NJ, USA) for Th17. Polarized cells were harvested for further analysis at the indicated time points.
+ Open protocol
+ Expand
5

Cell Culture Protocols for Leukemia and Vero Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human leukemia cell lines K562, TCCY-T315I and Ba/F3 were received from Prof. Yuko Sato (Tokyo, Japan). The Ba/F3 cells with T315I, Y253H and E279K were created as previous reported [20 (link)]. The African green monkey kidney (Vero) cell lineage (ATCC CCL-81™) was used in this study. Vero cells were grown in Dulbecco’s modified Eagle’s medium (DMEM, Sigma-Aldrich, Ho Chi Minh City, Vietnam) and other cells were grown in Roswell Park Memorial Institute 1640 medium (RPMI 1640, Sigma-Aldrich, Ho Chi Minh City, Vietnam) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (ThermoFisher Scientific, Ho Chi Minh City, Vietnam), 100 IU/mL penicillin, and 0.1 mg/mL streptomycin (P4333, Sigma-Aldrich, Ho Chi Minh City, Vietnam) in a humidified incubator of 5% CO2 at 37 °C.
+ Open protocol
+ Expand
6

Glioblastoma Primary Brain Tumor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used previously established primary brain tumor initiating cell lines (BTIC)-10 and -12 derived from patients with IDH wild type glioblastoma as described15 (link),41 . The Department of Neuropathology, University of Regensburg (MJR), verified the patients’ diagnoses and WHO grade.
Tumor cells were maintained in RHB-A (Y40001, Takara), supplemented with 20 ng/ml of EGF (130097751), bFGF (130093842) (both Miltenyi Biotech), and 50 U (v/v) Penicillin/0.05% (v/v) Streptomycin (P4333) (Sigma-Aldrich) at 37 °C, 5% CO2, 95% humidity in a standard tissue culture incubator. Progenitor features of BTICs were verified by clonogenicity assays, flow cytometry (CD133, CD15, CD44, A2B5), immunocytochemistry (Nestin, Sox2, GFAP), and tumor take in an immunocompromised mouse model (female NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ). BTICs were lentivirally transduced to achieve stable expression of the nuclear fluorescent protein H2B Dendra2, as described61 (link).
The ethics board of the University of Regensburg, Germany, approved the use of human material for this study (No° 11-103-0182) and all patients gave written informed consent. All methods were performed in accordance with the relevant guidelines and regulations.
+ Open protocol
+ Expand
7

Isolation and Culture of Human NK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Preparation and culture of peripheral blood NK cells Polyclonal primary human NK cells were isolated by negative selection from lymphocyte-enriched buffy coat residues derived from anonymous healthy donors as previously described. 23 Briefly, peripheral blood mononuclear cells (PBMCs) were isolated from the buffy coat by centrifugation using Ficoll-Paque Plus according to the manufacturer's instructions (GE Healthcare). NK cell isolation was performed by negative immunomagnetic bead isolation (EasySep® Human NK Cell Enrichment Kit, Stemcell Technologies) according to the manufacturer's instructions. Primary human NK cells were cultured for 7-14 days in Iscove's modified Dulbecco's medium (IMDM, I3390, Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% autologous human serum, 2 mM L-glutamine (G7513, Sigma-Aldrich, St. Louis, MO, USA), 100 U ml -1 penicillin-100 μg ml -1 streptomycin (P4333, Sigma-Aldrich, St. Louis, MO, USA), 1× non-essential amino acids (M7145, Sigma-Aldrich, St. Louis, MO, USA), 1 mM sodium pyruvate (S8636, Sigma-Aldrich, St. Louis, MO, USA) and 200 U ml -1 human interleukin (IL)-2 (PeproTech, Rocky Hill, NJ, USA) before use in experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!